
Biotech operations
Assessing the facility costs of contamination
Include investigation, rework, downtime, and support labor when reviewing a contamination event. Use site records rather than assumed costs.
Review access, training, product approvals, and documentation before research space takes on manufacturing work. Assign owners for the changes.

The move from an R&D lab to a GMP manufacturing facility is not a facilities upgrade. It is a fundamental change in the rules under which every operational activity — including cleaning — is designed, performed, documented, and reviewed.
Suppose a research team plans to begin GMP manufacturing. Assess cleaning requirements against the intended product and process before deciding which research procedures can be retained. Research laboratories may also have formal safety and quality requirements.
In drug manufacturing, 21 CFR 211.67 requires written equipment-cleaning procedures and records. Define qualification, validation, materials and documentation through the applicable requirements and quality system.
Review these areas when planning the transition:

Include cleaning validation in project planning where required. Define acceptance criteria, sampling, analytical methods and approvals before execution. Allow for investigation of unexpected results.
The documentation build that accompanies validation is substantial: validation protocol, execution records, analytical data, exception reports for any cycles that required investigation, and the final validation report that summarizes all of it. That report then becomes part of the controlled document system that must be maintained, referenced in production SOPs, and updated whenever the cleaning process changes materially.

Review gowning and segregation for the intended manufacturing process. Existing research controls may need revision, but their adequacy should be assessed rather than assumed.
Define gowning and removal sequences from the process risks and applicable requirements. Garment removal is not automatically the reverse of donning. Train cleaning personnel on the approved site procedures.
Segregation — between product campaigns, between different products if multi-product manufacturing occurs, between open and closed processing areas — has direct implications for cleaning scope and sequence. Campaign cleaning (full room and equipment clean between product campaigns) is a distinct, higher-intensity activity from the routine inter-batch cleaning that occurs during a single campaign. Both must be defined in SOPs, and both must generate records that clearly identify which type of cleaning was performed.
Include these potential gaps in the transition review:

Involve operations, quality and cleaning personnel during planning. Agree on procedures, qualification responsibilities and training before the relevant work begins. Base the service scope on the actual process and facility.
Discuss scope through our GMP cleaning services. See our biotech industry page for the sector overview, or Request a proposal for your facility.